Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)

Stopped early · Not applicable · Has a placebo group

Conditions studied: Vesicoureteral Reflux

In brief

The purpose of this research is to validate the common administration of oral midazolam to children prior to voiding cystourethrogram (VCUG) to see if this will significantly decrease children's anxiety and make the experience less traumatic.

Key facts

Study ID

NCT00894465

Run by

Washington University School of Medicine

People needed

44

Starts

2006-08-01

Expected to finish

2009-08-01

Last updated by the study team

2016-12-09

Who can join

Age: 2 and older, up to 6. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 2-6 years
• Toilet trained
• English speaking
• Already scheduled for VCUG

You may not qualify if…

• Allergic to midazolam
• Active UTI
• Known urethral stricture
• Known urethral reconstruction
• Has history of abnormal sensation in pelvic area
• Has history of sexual abuse
• Has severe developmental delay
• Has diagnosis of anxiety disorders

Where it is running

• Washington University — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.